LivaNova outlines 6%-7% revenue growth for 2026 as core businesses expand and OSA launch nears
Source: SeekingAlpha
2026-02-25 17:28:20 ET
More on LivaNova PLC
- LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript
- LivaNova PLC 2025 Q4 - Results - Earnings Call Presentation
- LivaNova PLC (LIVN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- LivaNova PLC Non-GAAP EPS of $0.86 beats by $0.05, revenue of $360.9M beats by $6.59M
- Seeking Alpha’s Quant Rating on LivaNova PLC
Read the full article on Seeking Alpha
For further details see:
LivaNova outlines 6%–7% revenue growth for 2026 as core businesses expand and OSA launch nears
LivaNova PLC
NASDAQ: LIVN
LIVN Trading
-2.37% G/L:
$58.42 Last:
404,196 Volume:
$59.65 Open:
LIVN Latest News
February 25, 2026 06:00:00 am
LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
LIVN Stock Data
$3,643,826,817
54,059,472
0.04%
98
N/A
Medical Equipment & Supplies
Healthcare
GB
London
